Seòmar agus comataidhean

To date there have been two call-off contracts under the Multiple Supplier Framework Agreement for Maritime Consultancy Services. They have a combined total value of £82,170.

The Scottish Government has listened to concerns that independent hospices have about the recruitment and retention of staff, and will continue to do so.

As Integration Joint Boards (IJBs) are responsible for the governance, planning, and resourcing of adult palliative care services, including hospices, using the integrated budget under their control, we will continue to work with Chief Officers to support longer term sustainable planning and commissioning for the hospice sector, and will work jointly to develop a national guidance framework to support and improve consistency of local planning and commissioning.

The Scottish Government has fully funded Network Rail Scotland to meet the assessment of its requirements as carried out by the independent rail regulator for the next five year rail investment Control Period (2024-29).

The total funding for the rail sector in Scotland for financial year 2023-2024 alone is circa £1.4 billion. This is compared to pre-pandemic levels of around £1 billion, demonstrating a significant increase in investment by the Scottish Government.

Scottish Ministers’ priorities remain focussed on a high-performing, efficient and safe rail network. These objectives are fully aligned with ScotRail and Caledonian Sleeper so that best value is secured for Scotland’s rail passengers, communities and businesses.

Where the ORR has determined increases in spend, such as operations to adapt to climate change, the Scottish Government has accepted and fully funded these recommendations, in order to strike the right balance in this Control Period among operations, maintenance and renewals.

The Digital Prescribing and Dispensing Pathways (DPDP) Programme is being developed, and it is intended to replace the paper prescription with a digital solution in community settings. The programme has been commissioned and funded by the Scottish Government. It is being jointly delivered by NHS National Services Scotland (NSS) and NHS Education for Scotland (NES) in collaboration with stakeholders across Scotland.

The inclusion of prescriptions for stoma items has been raised by the Chief Pharmaceutical Officer with the DPDP programme team, and consideration is being given as to how stoma items can be brought within the scope of the programme.

The Scottish Government remains committed to ensuring that everyone who needs it can access seamless, timely and high-quality palliative care.

We are currently developing a new National Strategy for Palliative and End of Life Care for Scotland. As part of this work, we are reviewing the information and evidence we have, and need, to develop the strategy. This includes gathering data on current and projected needs for palliative care at a population level, mapping governance, services and support across Scotland, and building on our understanding of people’s experiences of palliative and end of life care.

The outputs of this work will give us a clearer picture of the delivery and accessibility of palliative care across Scotland, and will inform a new strategy that reflects what really matters to people experiencing serious illness, dying and bereavement.

Following the Scottish Government’s 2020 consultation on the regulation of non-surgical cosmetic procedures (that pierce or penetrate the skin), officials are working on introducing secondary legislation to enable HIS to regulate independent healthcare services, including non-surgical cosmetic procedures, provided by pharmacists and pharmacy technicians from premises other than registered pharmacies, and/or which are provided outwith the terms of NHS contracts.

In addition, officials are engaging with the UK Department of Health and Social Care in regard to their recent consultation and working with stakeholders including healthcare professionals, hair and beauty industry representatives and Environmental Health Officers to consider the potential scope of further regulation in Scotland.

The Scottish Government remains committed to ensuring that everyone who needs it can access seamless, timely and high-quality palliative care.

We have appointed a National Clinical Lead for Palliative and End of Life Care to drive this, supported by a Clinical and Practice Advisory Group and a wide-reaching Strategy Steering Group.

The Steering Group is currently reviewing the information and evidence we have and need to develop the strategy, including mapping services and support across Scotland.

The certification of a person’s death is a matter that falls solely within the clinical responsibility of medical practitioners, who require to be satisfied to the best of their knowledge and belief as to the cause of death.

Following a post mortem examination, the pathologist will ordinarily certify the cause of death. In some cases, an ‘interim’ death certificate is issued by the pathologist indicating that the cause of death is unascertained until the results of further analysis - including but not limited to histopathology, toxicology and neuropathology - are obtained. This certificate allows the death to be registered and the body to be released to the family to allow funeral arrangements to be made. Once all analysis has concluded and the final cause of death is confirmed, the interim death certificate is then amended. However, in a small percentage of cases the pathologist is unable to determine a cause of death even after all such analysis is done.

In relation to post mortem examinations instructed by COPFS from 1 January 2023 to 31 August 2023, the pathologist was unable to determine a cause of death after full analysis in 134 cases. It is not presently possible to confirm the number of examinations where a cause of death was able to be determined as, in some cases, the final post mortem report confirming the cause of death has not yet been finalised and only interim causes of death have been issued.

Where a pathologist is unable to determine a cause of death, they will include in their report as much information as possible about their findings to assist nearest relatives with possible explanations for the death having occurred. COPFS will provide that information to relatives when advising them of the final cause of death.

Last year, Scottish Enterprise (SE), working with Innovate UK, invested £15m to establish the state-of-the-art Medicines Manufacturing Innovation Centre. The facility works with a range of partners in the pharmaceutical industry to conduct research and development, creating leading edge solutions for the manufacture of medicines.

In addition, just a few weeks ago, SE committed around £10m to support the creation of a new oligonucleotides manufacturing innovation centre, that will help pharmaceutical companies to undertake critical phase I and phase II trials to manufacture these highly effective new medicines.

In combination, these centres establish Scotland as a key player in the rapidly growing advanced manufacturing sector and we expect that they will act as a powerful magnet for inward investment and the creation of highly skilled jobs. This is already producing results e.g. Valneva will manufacture its world-first vaccine for the mosquito-bourne Chickungunya virus, in its new manufacturing facility in Livingston.

We are currently working to establish the existing levels of awareness of stroke symptoms and FAST through polling research. More detailed research exploring awareness of stroke symptoms and FAST is planned following the conclusion of this work and this will help inform future public awareness campaign content.

The 2023 edition of The National Clinical Guideline for Stroke states that more research into improving public awareness, and the appropriate action upon suspecting a stroke, is needed. Regarding pre-hospital identification of stroke, the Guideline also states that further evidence is required before a recommendation regarding the use of other screening tools that screen for non-FAST stroke symptoms could be made.

We will regularly review this position based on the best available evidence. The National Advisory Committee for Stroke will be asked to review any emerging evidence regarding public awareness and stroke screening tools and provide advice to the Scottish Government regarding the most appropriate action.